Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Alterations of juxtaparanodal domains in two rodent models of CNS demyelination.
Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.
A Case of Anti-aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Baló Concentric Lesions.
Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model.
Obesity diminishes synaptic markers, alters microglial morphology, and impairs cognitive function.
Verbal fluency deficits in clinically isolated syndrome suggestive of multiple sclerosis.
Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.
Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females.
Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis: A Failed Concept.
Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.
Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression.
Alexithymia in Neurological Disease: A Review.
Burden of risk variants correlates with phenotype of multiple sclerosis.
Comparison of diffusion-weighted imaging and contrast-enhanced T1-weighted imaging on a single baseline MRI for demonstrating dissemination in time in multiple sclerosis.
Squinting Through Layers of Fog: Assessing the Cost Effectiveness of Treatments for Multiple Sclerosis.
Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review.
Quantifying progression of multiple sclerosis via classification of depth videos.
Standardized magnetic resonance imaging acquisition and reporting in pediatric multiple sclerosis.
Ambulation and multiple sclerosis.
Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes.
Multiple sclerosis: Activation of cortical microglia linked to level of disability in patients with multiple sclerosis.
Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab.
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
Oral treatment with the herbal formula B401 protects against aging-dependent neurodegeneration by attenuating oxidative stress and apoptosis in the brain of R6/2 mice.
Modulation of BV-2 microglia functions by novel quercetin pivaloyl ester.
Pages
« first
‹ previous
…
380
381
382
383
384
385
386
387
388
…
next ›
last »